ASPS, which represents more than 11,000 physicians worldwide, cited “growing uncertainty about the benefits of medical and surgical interventions” for transgender youths and assessments that have “identified limitations in study quality, consistency, and follow-up alongside emerging evidence of treatment complications and potential harms” in its latest guidance.
